CervoMed Inc.
CRVOHealthcare|Biotechnology|US
$1.42
-0.03 (-2.07%)
DCF Value
$0.80
Tangible Book / Share
$1.15
Cash / Share
$1.30
Clinical Trials (4)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT07033481 Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia | Nonfluent Variant Primary Progressive Aphasia (nfvPPA) | P2 | Active | 20 | RCT, Double-blind | Neflamapimod, Placebo |
| NCT05869669 RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies | Dementia With Lewy Bodies | P2 | Completed | 159 | RCT, Double-blind | Neflamapimod, Placebo |
| NCT06815965 A Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies | Dementia With Lewy Bodies (DLB) | P2 | Completed | 26 | Open-label | neflamapimod |
| NCT06987643 A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke | Moderate to Severe Acute Ischaemic Stroke, Ischaemic Stroke | P2 | Completed | 45 | RCT, Double-blind | Neflamapimod, Placebo |